Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples